EX-21.1 15 tm2212882d6_ex21-1.htm EXHIBIT 21.1

 

Exhibit 21.1

 

List of Principal Subsidiaries of the Registrant

 

In connection with the separation of the Registrant from Ligand Pharmaceuticals Incorporated, the following entities will become wholly owned subsidiaries of the Registrant.

 

Wholly Owned Subsidiary   Place of Incorporation
Ab Initio Biotherapeutics, Inc.   Delaware
Crystal Bioscience, Inc.   California
Icagen, LLC   Delaware
Taurus Biosciences, LLC   Delaware
xCella Biosciences, Inc.   Delaware